Sarepta Therapeutics (SRPT) Says Eteplirsen Demonstrates a Continued Benefit on Walking Test Through 84 Weeks
Go back to Sarepta Therapeutics (SRPT) Says Eteplirsen Demonstrates a Continued Benefit on Walking Test Through 84 Weeks| SUPPORT.COM (NASDAQ: SPRT) | Delayed: 11.80 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.80 | 52 Week High | $1.14 | |||
| Open | $0.07 | 52 Week Low | $0.70 | |||
| Day High | $11.80 | P/E | 62.11 | |||
| Day Low | $11.80 | EPS | $0.19 | |||
| Volume | 200 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 18.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.79 | 52 Week High | $63.73 | |||
| Open | $18.79 | 52 Week Low | $8.00 | |||
| Day High | $18.79 | P/E | N/A | |||
| Day Low | $18.79 | EPS | $-5.69 | |||
| Volume | 7,048 | |||||
